Ledger.Open graph →
SEC Form D · filed September 23, 2019

Renibus Therapeutics, Inc

Offering
$3.4M
Sold
$3.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Southlake, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Dalton M. Dale · ST. PETERSBURG, FLDirectorBrian H. Schreiber · Washington, Washington, D.C.DirectorDesmond E. Mitchell · Luxembourg, LuxembourgExec · DirectorAnderson Growth Partners, LLC · Birmingham, ALExec · DirectorEric F. Rieders · Horsham, PADirectorRalph N. Cram · Northbrook, ILDirectorScott Poland · Culver City, CAExec · DirectorBrent Iloulian · Culver City, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗